ASTRAZENECA PLC (AZN)
Clinical trial NCT07611110 updates: 1. completion date: 2029-12-20 → 2030-06-06 2. primary completion date: 2029-02-13 → 2029-06-04
Clinical trial NCT07611110 updates: 1. completion date: 2029-12-20 → 2030-06-06 2. primary completion date: 2029-02-13 → 2029-06-04
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical